286) Ridley's studies using cadavers executed by hanging |
287) quently confirmed by dozens of subsequent studies using data from DNA sequences. |
288) Our previous studies using fMRI have demonstrated that |
289) that may guide hypothesis generation for studies using other imaging modalities. |
290) Mechanistic studies using rat everted gut sac model re |
291) osity, drug content and ex vivo diffusion studies using rat skin. |
292) We performed a meta-analysis of 13 studies using the Comprehensive Meta-Analy |
293) et been realized and no long-term in vivo studies using zonal chondrocytes have been |
294) Studies with murine models suggest that ma |
295) More well-designed studies with a larger sample size and long |
296) Improvements were observed in studies with and without cooling-induced p |
297) ancy increases the risk for SGA; however, studies with greater statistical power are |
298) y applied standard methods, especially in studies with high non-compliance due to ch |
299) ce weighting to provide greater weight to studies with larger sample size and more p |
300) Further studies with longitudinal observations are |
301) thods for assessing power in longitudinal studies with missing data, the impact on p |
302) Further prospective studies should be designed to elucidate th |
303) re benefit in selected cases, but further studies should be required to clearly demo |
304) Adequately powered studies should explore the potential benef |
305) Future studies should focus on broader clinical v |
306) Future studies should focus on testing other psyc |
307) Future studies should investigate specific calibr |
308) Future studies should prioritize the alpha taxono |
309) of parameter estimates obtained in other studies is given, pointing to a considerab |
310) ation in large population-based or cohort studies is needed. |
311) Further research with supporting clinical studies is required to identify the most e |
312) A limitation of these studies is that associations between these |
313) A problem for such studies is that designs with an optimal ef |
314) The challenge encountered in these studies is the non-identifiability because |
315) In many studies we wish to assess how a range of v |
316) In our previous studies, we confirmed that low-level laser |
317) As in previous studies, we found that predictable in-time |
318) Following promising preclinical studies, we report our first clinical expe |
|